Author:
Vincenzi Bruno,Frezza Anna Maria,Schiavon Gaia,Spoto Chiara,Addeo Raffaele,Catalano Vincenzo,Graziano Francesco,Santini Daniele,Tonini Giuseppe
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. André T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. N Engl J Med 350:2343–2351
2. Haller DG, Tabernero J, Maroun J et al (2011) Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 29:1465–1471
3. Attal N, Bouhassira D, Gautron M et al (2009) Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain 144:245–252
4. Won HH, Lee J, Park JO et al (2012) Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients. Cancer 118(11):2828–2836
5. Cancer Therapy Evaluation Program, Common terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003 ( http://ctep.cancer.gov ), Publish Date: August 9, 2006
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献